Interleukin enhancer binding factor 2 (ILF2), a transcription factor, regulates cell growth by
inhibiting the stabilization of mRNA. Currently, its role has gained recognition as a factor in …

Aims Hepatocellular carcinoma (HCC) is a primary malignancy of the hepatocyte. Interleukin
enhancer binding factor 2 (ILF2) plays a role in the development of HCC. However, the …

Interleukin enhancer‑binding factor 3 (ILF3) may function as a transcriptional coactivator and
has been reported to be involved in tumor proliferation and metastasis; however, its role and …

Abstract Interferon regulatory factor 1 (IRF1) has been suggested to act as a tumor
suppressor in human cancers. However, the clinical significance and biological function of …

Abstract Interferon regulatory factor 1 (IRF-1) is a tumor suppressor gene in cancer biology
with anti-proliferative and pro-apoptotic effect on cancer cells, however mechanisms of IRF-1 …

The IL6 family of cytokines, including IL6 and leukemia-inhibitory factor (LIF), are induced
during inflammation and are also expressed in many types of cancer where they play an …

Pancreatic cancer is one of the most malignant diseases in the world. Interferon regulator
factor 2 (IRF-2), an interferon regulatory factor, has been known to act as an oncogene in …

Cyclic adenosine monophosphate (cAMP) response element‐binding protein (CREB) is
overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). Interleukin …

Interferons (IFNs) play crucial roles in the development and treatment of cancer. Long non-
coding RNAs (lncRNAs) are emerging molecules involved in cancer progression. Here, we …

Abstract Background Long non-coding RNAs (lncRNAs) are essential indicators for
hepatocellular carcinoma. LncRNAs can exert the same functions as their antisense …